anz-logo
5th -
6th
February 2025 | 
Melbourne, Australia

3rd ANZ Biologics Festival 2025

5th -
6th
February 2025 | 
Melbourne, Australia
📆 Add to Google Calendar
Attendees
0 +
Companies
0 +
Speakers
0 +
In-Person Networking Hours
0 +
Case Studies
0 +

Excellence in Clinical Trials, Biologics Innovation and Expanded Manufacturing for Australia’s Future Biologics Industry.

With a biotechnology sector benchmarked for global excellence due to world-class facilities, researchers and regulation, Australia has a promising future for biologics innovation and manufacturing. The path ahead will require a focus on further commercial translation of research, and as such partnerships and collaborations will be critical. Expanding sovereign manufacturing in Australia will also play a massive role in uplifting the sector in the country.

The Australia Biologics Festival 2025 is Australia's premier conference that aims to gather the innovators, pioneers ,leaders in the Biologics fraternity including Biologics,Biosimilars, Vaccines, CGT and evolving therapeutics to showcase the latest from ideation to commercialisation phase and beyond. The themes of Investment in Australia and Promoting Clinical Trials in Australia in featured tracks. It brings the right environment to meet the entire biopharma fraternity under one roof.

Join us to bring investment to Australia’s bio sector and explore a wealth of opportunities in world-class clinical trials and biologics innovation as well as expanding the country’s manufacturing footprint.

FEATURED CONTENT

ABF-2024-Ebook2-Website-Cover-900-x-480
Investing in New Zealand Biopharma
ABF-2024-Ebook-Website-Cover-900-x-480
Biologics Manufacturing Landscape in Australia
MicrosoftTeams-image (13)
Cell & Gene Therapy in Australia and New Zealand
ABF24_-Speaker-Interview-website
Key Trends in the ANZ Biopharma Industry
Ebook-website-cover-900-x-480
Australia Biologics Industry Overview
ABF24_-website-cover-900-x-480
Infographic: Australia & NZ Biopharma Market
ABF23_Ebook-cover-1500-x-1500-1-1024x1024
Part 2: Key Future Trends & Innovations in the Australian Biopharma Industry 2023
ABF23_Speaker-inteview-cover-1024x1024
Key Future Trends & Innovations in the Australian Biopharma Industry 2023
3rd ANZ Biologics Festival 2025
.
.
.
.
.
.
.
.

THANK YOU TO OUR SUPPORTING PARTNERS









PAST SPONSORS

3rd ANZ Biologics Festival 2025

Past Speakers

Anne_Collis

Anne Collins

Chief Executive Officer

Sementis ,
Australia
Balaji-Somasundaram_photo_profile-4

Balaji Somasundaram

Senior CMC Project Manager

Denteric
Australia
Craig-Newton_photo_profile

Craig Newton

Director

VivaZome Therapeutics
Australia
Gavin-Painter_photo_profile-3

Gavin Painter

Professor

Victoria University of Wellington-Ferrier Research Institute
Wellington, New Zealand
George Wang

George Wang

Vice President, Discovery and Preclinical Services

WuXi Biologics
Ian-Nisbet_photo_profile

Ian Nisbet

Chief Operating Officer

Cartherics
Australia
Jerry-Kanellos_photo_profile-4

Jerry Kanellos

Chief Scientific Officer

Immuron
Australia
Jim Vadolas photo

Jim Vadolas

Group LeaderGroup Leader, Immunohaematology Research Group

Hudson Institute of Medical Research
Australia
John-Power_photo_profile

John Power

Group Leader- Regulated Biomanufacturing,

CSIRO
Australia
MicrosoftTeams-image (21)

Keith Chappell

Associate Professor

University of Queensland
Australia
Larisa-Chisholm_photo_profile

Larisa Chisholm

Chief Operating Officer

Denteric,
Australia
Lucas-Chan_photo_profile

Lucas Chan

Scientific Founder & Chief Scientific Officer

CellVec
Singapore
MicrosoftTeams-image (2)

Mark Womack

Chief Executive Officer,

Biocina
Australia
Mike-Gerometta_photo_profile-5

Mike Gerometta

Head of Process Development, Analytical & Formulation Science

Opthea
Australia
Nicole-Van-Der-Weerden_photo_profile

Nicole Van Der Weerden

Chief Operating Officer

Arovella therapeutics
Australia
Pall-Thordarson_photo_profile

Pall Thordarson

Professor & Director- RNA Institute,

UNSW
Australia
Pat Thomas

Pat Thomas

Senior Manager- Supply Chain

Amgen
Australia
Paul-McDonald_photo_profile

Paul McDonald

Chief Executive Officer

IDT
Australia
Penelope-Lane_photo_profile-3

Penelope Lane

CEO & Managing Director

Esfam Biotech
Australia
Philippe Grimme

Philippe Grimm

Business Development & Marketing Director

SGS VITROLOGY
Rasa Ruseckaite

Rasa Ruseckaite

Deputy Head, Clinical Outcomes Data Reporting And Research Program (CORRP), Qualitative Research

Monash University
Australia
Simon-Buensch_photo_profile-3

Simon Buensch

Vice President Manufacturing & Site Head – Parkville

CSL Seqirus
Australia
Susie-Nilsson_photo_profile-5

Susie Nilsson

Research Director Biomedical Manufacturing

CSIRO
Australia
Tam-Nguyen_photo_profile

Tam C. Nguyen

Deputy Director of Research

St. Vincent’s Hospital Melbourne
Australia
Tertia-Dex_photo_profile

Tertia Dex

Chief Manufacturing & Development Officer

HaemaLogiX
Australia
Tim-Oldham_photo_profile

Tim Oldham

CEO and Managing Director

Adalta
Australia
Xenia Sango

Xenia Sango

CEO and Managing Director

Vivazome Therapeutics
Australia

DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

BIOPHARMA/BIG PHARMA/ACADEMIC
Limited Super (6th September 2024)
SGD 1,880

Limited Special (1st November 2024)
SGD 2,150 

Early Bird (3rd January 2024)
SGD 2,420

Standard Price
SGD 2,690

Limited Group Packages
  • BUY2,GET3
  • BUY3,GET5

Poster Presentation:
SGD 400 
Site Tour: 
SGD 400
SOLUTION PROVIDER
Limited Super (6th September 2024)
SGD 3,710

Limited Special (1st November 2024)
SGD 4,040

Early Bird ((3rd January 2024)
SGD 4,250

Standard Price
SGD 4,590
Group Discount for Solution Providers & General Public:
Buy 3 and get 10% off, Buy 5 get 20% off, Buy 6 and above, get 25% off
Site Tour:
SGD 400
What's New?
  • New Track on Next Generation RNA Therapeutics
  • New Track focused on Cell & Gene Therapy in the ANZ Region
  • Detailed discussion on biologics processing/ manufacturing innovations and best practices
  • Featuring digitalization, AI and Machine Learning for manufacturing efficiencies 
  • Meet the leaders from Biologics, CGT and RNA Therapeutics (including mRNA vaccines) together
ANZ Biopharma Poster Presentation In Conjunction With 2nd Australia Biologics Festival, Melbourne, Australia

Biopharma in Australia and New Zealand is a burgeoning sector, driven by robust research and innovation. The region boasts a strong biotechnology infrastructure, fostering collaborations between academia and industry.

Australia and New Zealand's biopharma companies are actively engaged in developing novel therapies for various diseases, contributing to the global healthcare landscape. Supported by favorable regulatory environments, these nations are attracting investments and establishing themselves as significant players in the biopharmaceutical industry.

At the 2nd Australia Biologics Festival conference, we propose to “feature” the top research work done by the biopharma industry and the academic & research institutes and solution providers from the ANZ region and beyond. The poster presentation will be viewed by 300+ Biopharma industry professionals from top notch biopharma companies.

Some suggested themes for the posters include, but are not limited to:

  • Innovative Platform Technology for Biologics
  • Progress Updates on Biologics Pipeline (including Vaccines, Cell & Gene, Protein, Antibodies, Biosimilars and other biologics)
  • Novel Discovery Techniques in Biologics
  • New technologies to help advancement in the biologics research & manufacturing
  • New Modalities, development and application
  • Innovations in bioprocessing including material and/or process technology to help cut cost and increase efficiency

Abstracts & Poster PDF Submission Guidelines:

  • Abstracts may only be sent to [email protected] by 30th November 2023.
  • All abbreviations should be defined at the time of their first citation in the text. Do not use abbreviations in the title.
  • The first author is responsible for submitting the work and it is understood that the other authors are aware, read the abstract and approve it for submission.
  • The final version of the poster may be submitted to the organizing committee in PDF format by 1st Feb 2024.

On-site Poster Presentation Guidelines:

  • If a poster abstract is selected for presentation, the presenting author must register to attend the Conference. Presenting authors are responsible for all expenses related to attending the Conference, including but not limited to poster print-out, airfare, registration, accommodations, and ground transportation.
  • The poster session is 30 minutes on both conference days.
    Poster Set-up and Removal information will be shared prior to the start of the conference.
  • Interested in giving a presentation? Enquire now...

FEATURED CONTENT

ABF-2024-Ebook2-Website-Cover-900-x-480
Investing in New Zealand Biopharma
ABF-2024-Ebook-Website-Cover-900-x-480
Biologics Manufacturing Landscape in Australia
MicrosoftTeams-image (13)
Cell & Gene Therapy in Australia and New Zealand
ABF24_-Speaker-Interview-website
Key Trends in the ANZ Biopharma Industry
Ebook-website-cover-900-x-480
Australia Biologics Industry Overview
ABF24_-website-cover-900-x-480
Infographic: Australia & NZ Biopharma Market
ABF23_Ebook-cover-1500-x-1500-1-1024x1024
Part 2: Key Future Trends & Innovations in the Australian Biopharma Industry 2023
ABF23_Speaker-inteview-cover-1024x1024
Key Future Trends & Innovations in the Australian Biopharma Industry 2023

Don't Just Take Our Word For It

HEAR FROM OUR CLIENTS

Very educating and inspiring. I thought that careful thought was put into the topics and time allotted for the presentation

Olivia Newton-John Cancer Research Institute,  
 

The most representative conference I have been to yet in Australia of the challenges and capabilities of Australian biologics, particularly cell and gene therapy. When I saw 'biologics festival', I thought it would focus mainly on therapeutic recombinant proteins and antibodies, but the spread of gene and cell therapy included was worth attending for!

ATMP Sweden,  
 

Greatly appreciated the efforts by the organisers to arrange scheduled meetings with KOLs present at the conference. This was an initiative that I hadn't previously seen take place elsewhere and it allowed for fruitful discussion and engagement between attendees and booth exhibitors.

Bio-Strategy Delivering Technology,  
 

#BUZZ ABOUT THE EVENT

SIMILAR EVENTS

anz-logo
3rd ANZ Biologics Festival 2025

Download Post Event Report Form

Download Attendee List

Download Prospectus Document Form

Download Brochure Document Form

Sponsorship Form

Download Agenda Form

Apply For Speaking Opportunity

Download Featured Content Form

Download Ebook

Download Ebook

Download List of Biopharma, CMO, CRO, CDMO and Big Pharma in China and Taiwan Brochure

Download Strategic Consulting Brochure

Download Case Study Consulting Digital Disruption

Download Case Study Consulting Revolutionizing Biopharmaceuticals

Download IMAPAC Custom Events Prospectus

Download Case Study : Fill-Finish Solution provider increasing its market share

Download Case Study : European CMO expanding into APAC

Download Case Study : China CDMO's New Gene Protein Facility Opening

Download Biologics Newsletter

Download Cell and Gene Therapy Newsletter

Download Vaccines Newsletter

Download 1:1 Networking Meetings Case Study- High-end assembly solutions provider

Download 1:1 Networking Meetings Case Study- IT/Software Solution provider

Download 1:1 Networking Meetings Case Study- Biopharma Courier Service Provider